/Investor DB

RTW Investments L.P. — 2018 Investments

3 investments dated 2018 · listed companies and verified rows first · show all

Milestone Pharmaceuticalsmilestonepharma.comin𝕏Oct 2018 · $80M

Milestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.

BiotechDigital HealthHealthtechMedical DevicesMontreal, US

Ela Borenstein(Director)Francis Plat(Executive Officer)Yves Rosconi(Director)Scott Weiner(Director)Martin Maguire(Executive Officer)Philippe Douville(Executive Officer, Director)

Co-investorsPappas CapitalAmplitude Venture CapitalDomain AssociatesForbion

Windwardwindward.aiin𝕏Jun 2018

Windward delivers AI-powered operational intelligence for maritime security and commercial applications, fusing behavioral analytics and multi-sensor data to detect threats and opportunities.

AI & Machine LearningData & InfrastructureDefense TechTel Aviv

Amiad Daniel(Executive Officer, Director)Matan Peled(Founder)inAmi Daniel(Founder)

BoardDov Gatmon(Director)Patrick Poon(Director)Eden Shochat(Director)in

Co-investorsAlephFTV CapitalThompson Hutton, LLCJanus Henderson InvestorsPivotal Life SciencesQiming Venture Partners+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Attune Pharmaceuticals

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.